Event Recordings
Day 1 | Day 2
Session VII: Drug Approval Process
Moderator: Mathai Mammen, MD, PhD
Transitioning Gene Therapy to Main Stream Therapy
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research (CBER), FDA
Disparities in Clinical Trial Enrollment
What will it take to close the gap?
Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research FDA
The Inflation Reduction Act
Some Implications for Drug Innovation
Mark McClellan, MD, PhD, MPA
Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy, Duke-Margolis Center for Health Policy
Advancing Alternative Methods in Regulatory Science
Namandjé Bumpus, PhD
Chief Scientist, FDA
Session VII: Panel Discussion
Session VIII: Drug Development III
Moderator: Levi Garraway, MD, PhD
Connecting the Dots in R&D
Frank Nestle, MD
Global Head of Research & CSO, Sanofi
Improving Drug Discovery Success Rates through Genetics and Genomics
John Lepore, MD
Senior Vice President of Research, GSK
Targeting Strategies to Enhance Therapeutic Efficacy
Fiona Marshall, PhD
President, Novartis Institutes for BioMedical Research
Our Relentless Pursuit of Transformational Medicines for Patients
A Janssen R&D Perspective
John Reed, MD, PhD
Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
Cardiac Myosin Modulation for Heart Failure
Fady Malik, MD, PhD
Executive Vice President of R&D, Cytokinetics
Session VIII: Panel Discussion
Session IX: Making Transitions with Biopharma Discussion
Moderator: Sandra Horning, MD
Speakers:
Daniel O’Day, MBA
Chairman and CEO, Gilead Sciences, Inc.
Merdad Parsey, MD, PhD
Chief Medical Officer, Gilead Sciences
Session X: Foundations Role in Drug Development
Moderator: Hannah Valantine, MD
Advancing Cell and Gene Therapies
It’s a Partnership
Maria Millan, MD
President and CEO, CIRM
A New Breed of Cancer Non-Profit
Driving Research and Accelerating Cures
Louis DeGennaro, PhD
President and CEO, The Leukemia & Lymphoma Society
Pushing the Boundaries of Science with Cutting Edge Technology and Research Innovation
Nancy Brown
CEO, American Heart Association
Session X: Panel Discussion
Session XI: Nobel Laureate Panel Discussion
Moderator: Marc Tessier-Lavigne, PhD
Speakers:
Carolyn Bertozzi, PhD
Nobel Laureate 2022; Baker Family Director of Stanford ChEM-H
Jennifer Doudna, PhD
Nobel Laureate 2020; Professor in Biomedical and Health Sciences, UC Berkeley
Brian Kobilka, MD
Nobel Laureate 2012; Helene Irwin Fagan Chair of Cardiology, Professor, Department of Molecular and Cellular Physiology, Stanford University
Roger Kornberg, PhD
Nobel Laureate 2006; Mrs. George A. Winzer Professor of Medicine, Stanford University